Gene Therapy Innovation and Manufacturing Centre

Accelerating the development of gene therapies into life-changing treatments for patients.

The Gene Therapy Innovation and Manufacturing Centre (GTIMC) has been formed as part of the Innovation Hubs for Gene Therapies. The network of Innovation Hubs for Gene Therapies is a new UK initiative designed to advance the clinical development of new genetic treatments through the production of clinical grade vectors, alongside translational support and regulatory advice.

The Sheffield Innovation Hub will dramatically broaden the scope of gene therapy research in the UK. The Sheffield centre brings together partners from the North of England, the Midlands and Wales to advance knowledge on gene therapies so that we can translate scientific discoveries into new and exciting treatments for patients.

About us

Photo of decal on winder in the Gene Therapy Innovation and Manufacturing Centre

About us

Our partners

Research using lab equipment in the Gene Therapy Innovation and Manufacturing Centre

Our people

What we do

Manufacturing

Process Innovation

scientist in SITraN wearing mask and looking at a sample

Translational Support

Training and Skills

News

HRH Princess Anne officially opens the GTIMC at the University of Sheffield

14 November 2024

Princess Royal opens pioneering Gene Therapy Innovation and Manufacturing Centre

Her Royal Highness, The Princess Royal, officially opened the Gene Therapy Innovation and Manufacturing Centre (GTIMC) at the University of Sheffield today (2 October 2024).

Professor Dame Pamela Shaw in front of the SITraN building

21 June 2024

A career dedicated to treating the ‘cruellest disease’

When the University of Sheffield’s Professor Dame Pamela Shaw first met patients with motor neurone disease (MND), little was known about the devastating condition. Since then, she has dedicated her career to improving the prospects for those living

3 November 2023

New research institute to accelerate the search for a cure for MND

The new UK Motor Neuron Disease Research Institute, or UK MND RI, aims to discover new treatments that could ultimately mean MND becomes a curable condition.

16 October 2023

Strategic partnership for economic growth in South Yorkshire

GTIMC host venue for signing new memorandum of understanding between South Yorkshire Mayoral Combined Authority (SYMCA) and Aviva Capital Partners Limited.